Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Netherlands
/
Materials
Create a narrative
DSM-Firmenich
ENXTAM:DSFIR Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Create a narrative
DSM-Firmenich
Popular
Undervalued
Overvalued
DSM-Firmenich
WA
Analyst Price Target
Consensus Narrative from 20 Analysts
Focusing On Taste, Texture, And Health Will Strengthen Future Prospects
Key Takeaways The merger of DSM and Firmenich focuses on high-growth segments, enhancing revenue through synergies and achieving significant earnings improvements. Divesting non-core assets sharpens the focus on consumer-centered businesses, improving revenue, cash flow, and aligning with health-conscious demand trends.
View narrative
€127.66
FV
23.0% undervalued
intrinsic discount
3.63%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Your Valuation for
DSFIR
DSM-Firmenich
Your Fair Value
€
Current Price
€98.34
8.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-658m
15b
2015
2018
2021
2024
2025
2027
2030
Revenue €15.4b
Earnings €300.5m
Advanced
Set as Fair Value